Pharmaceuticals

« The pharmaceutical industry is undergoing an unprecedented transformation. The rise of biotechnologies, the emergence of new therapeutic modalities, and the increasing integration of artificial intelligence are redefining the rules of the game. AI, in particular, is revolutionizing research by drastically reducing the costs of preclinical phases and accelerating innovation. In twenty years, the average time for a similar treatment to reach the market has decreased from eight years to one year, driven by agile players, notably startups, who are challenging the status quo. At the same time, the rapid expansion of subsidiaries in emerging countries and the transformation of commercial strategies – from sales force to market access – are imposing new dynamics. In this context, Akoya supports French and international companies in these transformations, helping them structure their organizations and effectively plan their workforce. Through medium/long-term projections, we enable our clients to anticipate their needs in skills and resources. Once this vision is clarified, we leverage our expertise in Organizational Design to create structures adapted to the Group's strategy, accompanied by an HR roadmap aligned with the company's long-term vision. While the pharmaceutical industry remains one of the most powerful and attractive sectors, especially in a post-pandemic world, talent management is now a major challenge. The distribution of talent across different functions and specialties remains uneven, and the pathways between positions are not always clear. In a context of key profile shortages and market volatility, attracting and retaining talent becomes a strategic issue. At Akoya, we support pharmaceutical companies in their Talent Acquisition, Talent Management, and Learning & Development policies. We help them harmonize their competency frameworks, structure clear and accessible internal mobility pathways, and enhance their attractiveness to recruit and retain the best talents. »